APA (7th ed.) Citation

E, A., L, K., J, W., DM, B., RE, J., M, H., . . . M, M. (2023). Telomerase inhibition is an effective therapeutic strategy in TERT promoter-mutant glioblastoma models with low tumor volume. Neuro-oncology, 25(7), 1275. https://doi.org/10.1093/neuonc/noad024

Chicago Style (17th ed.) Citation

E, Aquilanti, et al. "Telomerase Inhibition Is an Effective Therapeutic Strategy in TERT Promoter-mutant Glioblastoma Models with Low Tumor Volume." Neuro-oncology 25, no. 7 (2023): 1275. https://doi.org/10.1093/neuonc/noad024.

MLA (9th ed.) Citation

E, Aquilanti, et al. "Telomerase Inhibition Is an Effective Therapeutic Strategy in TERT Promoter-mutant Glioblastoma Models with Low Tumor Volume." Neuro-oncology, vol. 25, no. 7, 2023, p. 1275, https://doi.org/10.1093/neuonc/noad024.